Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma. [electronic resource]
Producer: 20090709Description: 449-55 p. digitalISSN:- 1465-3621
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Boronic Acids -- administration & dosage
- Bortezomib
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- pathology
- Neoplasm Staging
- Prognosis
- Pyrazines -- administration & dosage
- Remission Induction
- Retrospective Studies
- Survival Rate
- Transplantation, Autologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.